Ultrasonographic modification of liver steatosis and visceral fat induced by treatment with losartan and simvastatin in hypertensive normocholesterolemic obese patients

Trial Profile

Ultrasonographic modification of liver steatosis and visceral fat induced by treatment with losartan and simvastatin in hypertensive normocholesterolemic obese patients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Losartan (Primary) ; Simvastatin (Primary) ; Amlodipine
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 27 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top